array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "Gsk Consumer Health, Inc."
["slug"]=>
string(32) "4abba-us-gsk-consumer-health-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204"
["description"]=>
string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company."
["address_street"]=>
string(28) "184 Liberty Corner Rd Ste 78"
["address_place"]=>
string(6) "Warren"
["address_region"]=>
string(10) "New Jersey"
["founding_date"]=>
string(10) "1994-02-28"
["website_domain"]=>
string(7) "gsk.com"
["website_url"]=>
string(19) "https://www.gsk.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(300)
["article_count"]=>
int(449)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(96) "GSK builds the first laboratory with the maximum level of security in Tres Cantos | @diariofarma"
["snippet_en"]=>
string(120) "With a budget of 4.5 million euros, the new facility will have BSL-4 level and will be completed by the end of this year"
["url"]=>
string(118) "https://diariofarma.com/2024/03/05/gsk-construye-en-tres-cantos-el-primer-laboratorio-con-el-nivel-maximo-de-seguridad"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/28573fb4-d40e-4e42-b71f-f48a7c772ac2"
["source"]=>
string(15) "diariofarma.com"
["publication_date"]=>
string(10) "2024-03-05"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[1]=>
array(7) {
["title_en"]=>
string(62) "Biopharmaceutical company GSK and IGNIS agree to a Virtual PPA"
["snippet_en"]=>
string(138) "The virtual power purchase agreement between GSK and IGNIS will be possible thanks to two new solar plants that IGNIS will build in Spain."
["url"]=>
string(58) "https://www.energynews.es/gsk-e-ignis-acuerdo-ppa-virtual/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/7905f19e-59ef-4945-8571-e0fb8d42045e"
["source"]=>
string(13) "energynews.es"
["publication_date"]=>
string(10) "2024-02-28"
["categories"]=>
array(3) {
[0]=>
string(6) "Energy"
[1]=>
string(17) "Energy Management"
[2]=>
string(18) "Expansion & Growth"
}
}
[2]=>
array(7) {
["title_en"]=>
string(67) "No access from via Strozzi. Gsk, between car parks and laboratories"
["snippet_en"]=>
string(194) "A sign in Siena raises the alarm about a possible access gate to the GSK complex from Via Strozzi, but the plans exclude this hypothesis. GSK will build a new car park and expand internal roads."
["url"]=>
string(108) "https://www.lanazione.it/siena/cronaca/nessun-accesso-da-via-strozzi-gsk-tra-parcheggi-e-laboratori-39a6c30f"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b840a8ad-87e6-434f-89cb-98075194e4ec"
["source"]=>
string(12) "lanazione.it"
["publication_date"]=>
string(10) "2024-02-23"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[3]=>
array(7) {
["title_en"]=>
string(87) "GSK considering expanding its respiratory business with Verona Pharma and its COPD drug"
["snippet_en"]=>
string(87) "GSK considering expanding its respiratory business with Verona Pharma and its COPD drug"
["url"]=>
string(59) "https://www.merca2.es/2024/01/03/gsk-verona-pharma-1530796/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b38e2896-a81f-4186-a8b2-31e7a0f364aa"
["source"]=>
string(9) "merca2.es"
["publication_date"]=>
string(10) "2024-01-02"
["categories"]=>
array(3) {
[0]=>
string(20) "Business Development"
[1]=>
string(18) "Expansion & Growth"
[2]=>
string(25) "Business Model Resilience"
}
}
[4]=>
array(7) {
["title_en"]=>
string(53) "GSK invests 4 million in 6,000 solar panels in Aranda"
["snippet_en"]=>
string(206) "With this new project, the pharmaceutical multinational will generate more than 5,700 MWh per year in renewable energy, which represents 30% of the factory's consumption and a reduction of 1,500 tons of CO2"
["url"]=>
string(138) "https://www.diariodeburgos.es/noticia/zdf88e4df-d008-d3a6-dffa90b09071c6ba/202311/gsk-invierte-en-aranda-4-millones-en-6000-placas-solares"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4c9eb641-07c9-4e2e-8c0d-809393294272"
["source"]=>
string(17) "diariodeburgos.es"
["publication_date"]=>
string(10) "2023-11-04"
["categories"]=>
array(10) {
[0]=>
string(20) "Alternative Energies"
[1]=>
string(19) "Investment Requests"
[2]=>
string(6) "Energy"
[3]=>
string(17) "Energy Management"
[4]=>
string(33) "Materials Sourcing and Efficiency"
[5]=>
string(22) "Sustainable Investment"
[6]=>
string(19) "Green & Responsible"
[7]=>
string(13) "GHG Emissions"
[8]=>
string(18) "Expansion & Growth"
[9]=>
string(18) "General Investment"
}
}
[5]=>
array(7) {
["title_en"]=>
string(69) "SpringWorks Scores GSK Partnership Expansion, $225M Raise | BioSpace"
["snippet_en"]=>
string(178) "SpringWorks announced the expansion of its partnership with GlaxoSmithKline to develop nirogacestat in combination with GSK's Blenrep for relapsed or refractory multiple myeloma."
["url"]=>
string(68) "https://www.biospace.com/article/springworks-nirogacestat-bags-300m/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/55636483-b524-4cee-950c-6407d15d5151"
["source"]=>
string(12) "biospace.com"
["publication_date"]=>
string(10) "2022-09-08"
["categories"]=>
array(3) {
[0]=>
string(14) "Product Launch"
[1]=>
string(13) "Collaboration"
[2]=>
string(18) "Expansion & Growth"
}
}
[6]=>
array(7) {
["title_en"]=>
string(91) "GlaxoSmithKline -GSK- reinforces its oncology segment with new acquisition - CONSULTORSALUD"
["snippet_en"]=>
string(160) "GlaxoSmithKline or GSK for short is a pharmaceutical company of British origin with a great position in the world market, which occupies the number one position"
["url"]=>
string(62) "https://consultorsalud.com/glaxosmithkline-refuerza-oncologia/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/dfeb08f1-2d30-4323-86c8-6773d186954a"
["source"]=>
string(18) "consultorsalud.com"
["publication_date"]=>
string(10) "2022-04-21"
["categories"]=>
array(4) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(11) "Acquisition"
[3]=>
string(21) "Competitive Behaviour"
}
}
[7]=>
array(7) {
["title_en"]=>
string(69) "GSK reveals plans for one of Europe’s largest life science campuses"
["snippet_en"]=>
string(117) "GSK has set out a vision for a new campus in Stevenage, UK: which could create up to 5,000 jobs over the next decade."
["url"]=>
string(121) "https://www.biopharma-reporter.com/Article/2021/07/19/GSK-reveals-plans-for-one-of-Europe-s-largest-life-science-campuses"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8cacb102-8d4c-4ac8-b8d6-88e4f0c68b20"
["source"]=>
string(22) "biopharma-reporter.com"
["publication_date"]=>
string(10) "2021-07-19"
["categories"]=>
array(1) {
[0]=>
string(18) "Expansion & Growth"
}
}
[8]=>
array(7) {
["title_en"]=>
string(76) "Thermo Fisher snaps up GSK site in Ireland as part of its expansion campaign"
["snippet_en"]=>
string(243) "Thermo Fisher Scientific, which has been rapidly expanding its drug production, has yet another operation in its sights. | Thermo Fisher Scientific, which has been rapidly expanding its drug production, has yet another operation in its sights."
["url"]=>
string(114) "https://www.fiercepharma.com/manufacturing/thermo-fisher-snaps-up-gsk-plant-ireland-as-part-its-expansion-campaign"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/356e25b3-982b-467a-b34a-52b08510af48"
["source"]=>
string(16) "fiercepharma.com"
["publication_date"]=>
string(10) "2019-05-16"
["categories"]=>
array(2) {
[0]=>
string(17) "Production Issues"
[1]=>
string(18) "Expansion & Growth"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(28)
}
[1]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(26)
}
[2]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(26)
}
[3]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(21)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(20)
}
[5]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(18)
}
[6]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(17)
}
[7]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(16)
}
[8]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(15)
}
[9]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(14)
}
[10]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(14)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(13)
}
[12]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(10)
}
[15]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[16]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(8)
}
[19]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(6)
}
[22]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(6)
}
[23]=>
array(2) {
["name"]=>
string(6) "Crisis"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(21) "Cultural developments"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(6)
}
[27]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(5)
}
}
}
4abba-us-gsk-consumer-health-inc
Gsk Consumer Health, Inc.
Location
New Jersey
Founded
1994-02-28
Website
https://www.gsk.com
Articles
449 Articles
Category
Pharmaceutical Preparations
Description
GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company.
A sign in Siena raises the alarm about a possible access gate to the GSK complex from Via Strozzi, but the plans exclude this hypothesis. GSK will build a new car park and expand internal roads.
With this new project, the pharmaceutical multinational will generate more than 5,700 MWh per year in renewable energy, which represents 30% of the factory's consumption and a reduction of 1,500 tons of CO2
SpringWorks announced the expansion of its partnership with GlaxoSmithKline to develop nirogacestat in combination with GSK's Blenrep for relapsed or refractory multiple myeloma.
GlaxoSmithKline or GSK for short is a pharmaceutical company of British origin with a great position in the world market, which occupies the number one position
Thermo Fisher Scientific, which has been rapidly expanding its drug production, has yet another operation in its sights. | Thermo Fisher Scientific, which has been rapidly expanding its drug production, has yet another operation in its sights.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
